Back

Impact of phenotypic profile and genotype on ventricular tachycardia ablation outcomes in hypertrophic cardiomyopathy

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Arrhythmia management in patients with hypertrophic cardiomyopathy Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Augusto Meretta

Leiden University Medical Center, Leiden (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Prognostic significance of artificial intelligence quantified late gadolinium enhancement in hypertrophic cardiomyopathy
Doctor Y. Jeong (Daegu, KR)
Abstract Slides Video
Presentation thumbnail
Defibrillation threshold testing in hypertrophic cardiomyopathy: acute outcomes and long-term follow-up
Doctor Y. Bocchini (Bad Oeynhausen, DE)
Abstract Slides Video
Presentation thumbnail
Electromechanical predictors of haemodynamic and clinical efficacy of electro-mechanically optimised RV pacing for obstructive hypertrophic cardiomyopathy: a stratified analysis of EMORI-HCM
Doctor J. Mohal (London, GB)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of catheter ablation for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
Doctor A. Keresteci (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Predictors of recurrent ventricular arrhythmias and the impact of genetic testing in a hypertrophic cardiomyopathy patient cohort at long term follow up
Doctor H. Moore (Somerset nhs Foundation, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmia management in patients with hypertrophic cardiomyopathy

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Long-term outcomes of catheter ablation for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Atrial arrhythmia recurrence in hypertrophic cardiomyopathy: insights from repeat ablation
thumbnail
Congress Presentation
Catheter ablation of sustained ventricular tachycardia in patients with structural heart disease and mildly reduced or preserved ejection fraction: results of the Preserved-AVT multicenter registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources